Form 4 for ONC BeOne Medicines Ltd.
Accepted 2021-12-16 00:00:00 ET · period of report 2021-12-14 · accession 0001651308-21-000255 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-16 | 2021-12-14 | ONC | Huang Jane | CMO, Hematology | S - Sale+OE | $278.14 | -1,500 | 400 | -79% | -$417.2K |
| D | 2021-12-16 | 2021-12-14 | ONC | Huang Jane | CMO, Hematology | M - OptEx | $119.96 | +1,500 | 1,500 | New | +$179.9K |
| D | 2021-12-16 | 2021-12-14 | ONC | Huang Jane | CMO, Hematology | M - OptEx | $0.00 | -19.5K | 211.3K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares | 2021-12-14 | S | D | 300 | $274.54 | 1,200 | D | — | — | (F1) Each American Depositary Share represents 13 Ordinary Shares. (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.27 to $274.70, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. |
| 2 | Common | American Depositary Shares | 2021-12-14 | S | D | 200 | $281.64 | 100 | D | — | — | (F1) Each American Depositary Share represents 13 Ordinary Shares. (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $281.49 to $281.78, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. |
| 3 | Common | American Depositary Shares | 2021-12-14 | S | D | 100 | $278.79 | 300 | D | — | — | (F1) Each American Depositary Share represents 13 Ordinary Shares. |
| 4 | Common | American Depositary Shares | 2021-12-14 | M | A | 1,500 | $119.96 | 1,500 | D | — | — | (F1) Each American Depositary Share represents 13 Ordinary Shares. |
| 5 | Common | American Depositary Shares | 2021-12-14 | S | D | 100 | $284.52 | 0 | D | — | — | (F1) Each American Depositary Share represents 13 Ordinary Shares. |
| 6 | Common | American Depositary Shares | 2021-12-14 | S | D | 300 | $276.95 | 900 | D | — | — | (F1) Each American Depositary Share represents 13 Ordinary Shares. (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $276.57 to $277.37, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. |
| 7 | Common | American Depositary Shares | 2021-12-14 | S | D | 500 | $278.21 | 400 | D | — | — | (F1) Each American Depositary Share represents 13 Ordinary Shares. (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $277.78 to $278.67, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. |
| 8 | Derivative | Share Option (Right to Buy) | 2021-12-14 | M | D | 19,500 | $0.00 | 211,276 | D | $9.23 · — to 2029-06-04 | 19,500 Ordinary Shares | (F7) The number of securities underlying the option and the exercise price therefor are represented in ordinary shares. (F8) These securities vest over a four-year period as follows: 25% on June 5, 2020, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control. |